Trefoil Therapeutics Is A Clinical Stage Biotechnology Company Based In San Diegocaliforniafocused On Developing Innovative Therapies For Corneal Diseasesfounded In 2014The Company Is Known For Its Work On Tthx1114A Novel Engineered Fgf1 Compound Aimed At Treating Various Corneal Conditionsincluding Corneal Endothelial Dystrophyced This Condition Affects A Significant Portion Of The Populationparticularly Those Over 40 Years Old The Company Is Advancing Two Investigational Products Based On Tthx1114Which Are Designed To Restore Vision Loss By Stimulating The Regenerative Properties Of Endothelial Cellstrefoil S Research Has Shown Promising Results In Improving Visionreducing Corneal Edemaand Aiding Recovery From Surgical Damagethe Company Has Also Successfully Raised $72 13 Million In Funding From Various Investorssupporting Its Mission To Enhance The Lives Of Patients With Corneal Diseases
No conferences found for this company.
| Company Name | Trefoil Therapeutics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
